Make an online appointment at any of our 9 conveniently located offices.
Select a location to make an appointment.

|
* denotes required field |

The highly skilled Ophthalmic Consultants of Long Island team is proud to offer Lucentis an advanced prescription medication that treats neovascular (wet), age-related macular degeneration. Neovascular macular degeneration develops as blood vessels grow beneath the retina and begin to leak blood and fluid, which leads to light sensitivity, blind spots, distorted vision and vision loss.
Lucentis counteracts wet macular degeneration by blocking the chemical responsible for the progression of these abnormal blood vessels. As a result, patients are able to maintain their current vision or improve their vision with continued use of Lucentis. Clinical trials reported that more than 40 percent of patients demonstrated vision improvement and 95 percent of patients maintained their current vision.
Patients interested in Lucentis should contact the ophthalmologists at Ophthalmic Consultants of Long Island to receive a consultation and determine if Lucentis is right for them.
The OCLI eye doctors are leading Long Island macular degeneration specialists who also treat patients who suffer from diabetic retinopathy and retinal detachment.
In addition to treating macular degeneration, the doctors at OCLI also provide eye care treatments for Long Island LASIK and cataract surgery patients.